Research Trial for Moderate-to-Severe Plaque Psoriasis (154 Weeks)

Research Trial for Moderate-to-Severe Plaque Psoriasis (154 Weeks)

Study Summary

Who Can Participate?

Adults (≥ 18 years of age) who have plaque psoriasis, may be eligible to participate.

Inclusion Criteria: 

  • Body Mass Index (BMI) ≥ 18.5 kg/m2
  • Diagnosis of stable chronic plaque psoriasis (with or without psoriatic arthritis) for at least 6 months
  • Moderate-to-severe disease, with a Body Surface Area (BSA) ≥ 10% (i.e. 10 handprints)
  • Candidate for systemic therapy or phototherapy for psoriasis treatment

Participant Info:

  • No cost to participate or receive study medication
  • Regular visits with study doctors who are familiar with treating plaque psoriasis
  • Will receive investigational injected medication (active study drug) or placebo
  • Reimbursement for study-related expenses may be provided 

How Long Will The Study Last?

Participation will last about 154 weeks and involve about 23 visits to the study research site (plus 2 phone visits).

After you have completed the study, you may have the opportunity to continue receiving ORKA-001 through another study.  The study team will discuss this with you in further detail.

Click here to Register

For more information about this trial, please visit ClinicalTrials.gov

Ready to Find a Trial?

Start your journey here.
Find a Trial

Can’t Find a Trial Near You?

Complete a general registration to let us know who you are and what you’re interested in. We can keep your information on file and contact you when there is a trial that may be suitable for you.
General Registration

Privacy Policy

Last Revised: July 2024

I agree to the Privacy PolicyI do not agree

Registration

Enrolling:

Clinic:

Doctor:

Please fill in your contact details:

Find a Trial